Evaluation of the sialic acid content of LDL as a marker of coronary calcification and extracoronary atherosclerosis in asymptomatic hypercholesterolemic subjects

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 15, Issue 3, 1995, Pages 334-339

  Chappey, B ^a,b   Myara, I ^a,b   Giral, P ^b   Kerharo, G ^b   Plainfosse, M C ^b   Levenson, J ^b   Simon, A ^b   Moatti, N ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

atherosclerosis; B mode ultrasonography; low density lipoproteins; siliac acid; ultrafast computed tomography

Indexed keywords

LOW DENSITY LIPOPROTEIN; SIALIC ACID;

ADULT; AGED; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ULTRASOUND;

EID: 0028934601     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.15.3.334     Document Type: Article

References (42)

1. Lindberg G, Eklund GA, Gullberg B, Rastam L. Serum sialic acid concentration and cardiovascular mortality. Br Med J. 1991;302:143-146.
2. Waters PJ, Lewry E, Pennock CA. Measurement of sialic acid in serum and urine: clinical applications and limitations. Ann Clin Biochem. 1992;29:625-637.
3. Crook M. The determination of plasma or serum sialic acid. Clin Biochem. 1993;26:31-38.
4. Orekhov AN, Tertov VV, Mukhin DN. Desialylated low density lipoprotein: naturally occurring modified lipoprotein with atherogenic potency. Atherosclerosis. 1991;86:153-161.
5. Orekhov AN, Tertov VV, Sobenin IA, Smirnov VN, Via DP, Guevara J Jr, Gotto AM, Morrisset JD. Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J Lipid Res. 1992;33:805-817.
6. Ruelland A, Gallou G, Legras B, Paillard F, Cloarec L. LDL sialic acid content in patients with coronary artery disease. Clin Chim Acta. 1993;221:127-133.
7. La Belle M, Krauss RM. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. J Lipid Res. 1990;31:1577-1588.
8. Tertov VV, Orekhov AN, Sobenin IA, Morrisset JD, Gotto AM, Guevara J Jr. Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. J Lipid Res. 1993;34:365-375.
9. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham Study. Ann Intern Med. 1971;74:1-12.
10. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? JAMA. 1986;256:334-339.
11. Blankenhorn DH, Rooney JA, Curry JP. Noninvasive assessment of atherosclerosis. Prog Cardiovasc Dis. 1984;26:295-307.
12. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
13. Giral P, Filitti V, Levenson J, Pithois-Merli I, Plainfosse MC, Mainardi C, Gold A, Simon A, and the PCVMETRA Group. Relation of risk factors for cardiovascular disease to early atherosclerosis detected by ultrasonography in middle-aged normotensive hypercholesterolemic men. Atherosclerosis. 1990;85:151-159.
14. Giral P, Pithois-Merli I, Filitti V, Levenson J, Plainfosse MC, Mainardi C, Simon A, and the PCVMETRA Group. Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men. Arch Intern Med. 1991;151:950-956.
15. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993; 87(suppl II):II-56-II-65.
16. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia: ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb. 1993;13:1404-1411.
17. Tanenbaum SR, Dondos GT, Veselik KE, Prendergast MR, Brundage BH, Chomka EV. Detection of calcine deposits in coronary arteries by ultrafast computed tomography and correlation with angiography. Am J Cardiol. 1989;63:870-872.
18. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15: 827-832.
19. Ultrafast CT for coronary calcification. Lancet. 1991;337:1449-1450. Editorial.
20. Megnien JL, Sene V, Jeannin S, Hernigou A, Plainfosse MC, Merli I, Atger V, Moatti N, Levenson J, Simon A, and the PCVMETRA Group. Coronary calcification and its relation to extracoronary atherosclerosis in asymptomatic hypercholesterolemic men. Circulation. 1992;85:1799-1807.
21. Hoeg JM, Feuerstein IM, Tucker EE. Detection and quantification of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia. Arterioscler Thromb. 1994;14:1066-1074.
22. Frink RJ, Achor RWP, Brown AL, Kincaid OW, Brandenburg RO. Significance of calcification of the coronary arteries. Am J Cardiol. 1970;26:241-247.
23. Simons DB, Schwartz RS, Shredy PF, Breen JF, Edwards WD, Rumberger JA. Coronary artery calcification by ultrafast CT predicts stenosis size: a necropsy study. Circulation. 1990;82(suppl III):A-234.
24. Breen JF, Sheedy PF, Stanson AW, Rumberger J, Schwartz RS. Coronary Calcification Detected With Ultrafast CT as a Marker of Coronary Artery Disease. Chicago, Ill: Radiological Society of North America; 1990:1-224.
25. Simon A, Levenson J, Bouthier J, Safar M, Avolio P. Evidence of early degenerative changes in large arteries in human essential hypertension. Hypertension. 1985;7:675-680.
26. Cambillau M, Simon A, Amar J, Giral P, Atger V, Segond P, Levenson J, Merli I, Megnien JL, Plainfosse MC, Moatti N, and the PCVMETRA Group. Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. Arterioscler Thromb. 1992;12:1346-1352.
27. 1989 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens. 1989;7:689-693.
28. Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem. 1959;234:1971-1975.
29. Li K. Determination of sialic acids in human serum by reversed-phase liquid chromatography with fluorimetric detection. J Chromatogr Sci. 1992;579:209-213.
30. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977;83:346-356.
31. Janowitz WR, Agatson AS, Viamonte M. Comparison of serial quantitative evaluation of calcified coronary artery plaque by ultrafast computed tomography in persons with and without obstructive coronary artery disease. Am J Cardiol. 1991;68:1-6.
32. Sattler W, Kostner GM, Waeg G, Esterbauer H. Oxidation of lipoprotein Lp(a): a comparison with low-density lipoproteins. Biochim Biophys Acta. 1991;1081:65-74.
33. McGill HC. The cardiovascular pathology of smoking. Am Heart J. 1988;115:250-257.
34. Pelourdeau T, Filitti V, Assad N, Pithois-Merli I, Levenson J, Giral P, Cambillau M, Moatti N, Plainfosse MC, Simon A, and the PCVMETRA group. Risk factors and early extracoronary atherosclerotic plaques detected by two-site ultrasound imaging in hypercholesterolemic women. Cardiovasc Risk Factors. 1991;1:498-504.
35. Filipovic I, Schwarzmann G, Mraz W, Wiegandt H, Buddecke E. Sialic acid content of low-density lipoproteins controls their binding and uptake by cultured cells. Eur J Biochem. 1979;93:51-55.
36. Orekhov AN, Tertov VV, Mukhin DN, Mikhailenko IA. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun. 1989;162:206-211.
37. Camejo G, Lopez A, Lopez F, Quinones J. Interaction of low density lipoproteins with arterial proteoglycans: the role of charge and sialic acid content. Atherosclerosis. 1985;55:93-105.
38. Camejo G, Hurt E, Wiklund O, Rosengren B, Lopez F, Bondjers G. Modification of low density lipoprotein induced by arterial proteoglycans and chondroitin-6-sulfate. Biochim Biophys Acta. 1991;1096:253-261.
39. Hurt-Camejo E, Camejo G, Rosengren B, Lopez F, Ahlstrom C, Fager G, Bondjers G. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb. 1992;12:569-583.
40. Hurt E, Bondjers G, Camejo G. Interaction of LDL with human arterial proteoglycans stimulates its uptake by human monocyte-derived macrophages. J Lipid Res. 1990;31:443-454.
41. Basu SK, Brown MS, Ho YK, Goldstein JL. Degradation of low density lipoprotein-dextran sulfate complexes associated with deposition of cholesteryl esters in mouse macrophages. J Biol Chem. 1979;254:7141-7146.
42. Camejo G, Acquatella H, Lalaguna F. The interactions of low density lipoproteins with arterial proteoglycans: an additional risk factor? Atherosclerosis. 1980;36:55-65.